GLOBOCAN 2022

DOMINICAN REPUBLIC
Number of new cases Number of deaths Number of prevalent cases
(5-year)

20 171 11 744 51 313

Statistics at a glance, 2022
Males Females Both sexes
Population 5 517 509 5 538 865 11 056 374
Dominican
Incidence* Republic

Number of new cancer cases 10 735 9 436 20 171

Age-standardized incidence rate 186.7 150.5 167.0

Risk of developing cancer before the age 19.8 14.8 17.2

of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Prostate Breast Prostate

cases)**
Colorectum Cervix uteri Breast
Lung Colorectum Colorectum

Mortality*

Number of cancer deaths 6 176 5 568 11 744

Age-standardized mortality rate 100.4 85.8 92.0

Risk of dying from cancer before the age 9.8 8.9 9.3
of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Prostate Breast Prostate

deaths)**
Lung Cervix uteri Breast
Colorectum Lung Lung

Prevalence* Kilometers

0 250 500 1000

5-year prevalent cases 25 408 25 905 51 313

Top 5 most frequent cancers**

Males Females Both sexes

Prostate
Others
Others Breast
Others

Prostate

Stomach
Breast

Liver
Liver
Cervix uteri Cervix uteri
Lung Lung
Lung Colorectum
Colorectum Colorectum

Total: 10 735 Total: 9 436 Total: 20 171

Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent

1st Prostate 4 918 45.8% 1st Breast 3 244 34.4% 1st Prostate 4 918 24.4%

2nd Colorectum 906 8.4% 2nd Cervix uteri 967 10.2% 2nd Breast 3 244 16.1%

3rd Lung 896 8.3% 3rd Colorectum 876 9.3% 3rd Colorectum 1 782 8.8%

4th Liver 453 4.2% 4th Lung 724 7.7% 4th Lung 1 620 8.0%

5th Stomach 415 3.9% 5th Liver 396 4.2% 5th Cervix uteri 967 4.8%

- Others 3 147 29.3% - Others 3 229 34.2% - Others 7 640 37.9%

Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages

The Global Cancer Observatory | All rights reserved | January, 2024 Page 1
 Incidence, Mortality and Prevalence by cancer site

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Prostate 4 918 1 86.1 10.3 2 120 1 31.1 2.5 12 005 23.4

Breast 3 244 2 53.4 5.5 1 457 2 23.0 2.4 10 352 20.2

Colorectum 1 782 3 14.7 1.7 934 4 7.6 0.91 5 002 9.7

Lung 1 620 4 12.8 1.5 1 379 3 10.9 1.3 2 114 4.1

Cervix uteri 967 5 15.6 1.6 622 6 9.9 1.1 3 010 5.9

Liver 849 6 6.8 0.73 751 5 5.9 0.63 1 073 2.1

Stomach 767 7 6.2 0.72 587 7 4.7 0.54 1 131 2.2

Leukaemia 645 8 5.5 0.49 570 8 4.7 0.44 1 935 3.8

Pancreas 622 9 5.0 0.57 554 9 4.4 0.50 665 1.3

Brain CNS 405 10 3.4 0.33 315 10 2.7 0.28 1 488 2.9

Larynx 321 11 2.7 0.33 207 11 1.7 0.19 1 001 2.0

NHL 295 12 2.6 0.24 165 13 1.4 0.15 988 1.9

Thyroid 278 13 2.3 0.21 44 22 0.32 0.03 962 1.9

Bladder 252 14 2.0 0.22 117 15 0.87 0.09 737 1.4

Hodgkin lymphoma 233 15 2.0 0.18 62 19 0.53 0.05 847 1.7

Corpus uteri 209 16 3.4 0.42 61 20 0.95 0.12 729 1.4

Oesophagus 207 17 1.7 0.22 182 12 1.5 0.19 298 0.58

Oropharynx 188 18 1.6 0.19 85 17 0.67 0.08 512 1.00

Multiple myeloma 183 19 1.5 0.19 155 14 1.3 0.15 514 1.0

Ovary 167 20 2.7 0.27 112 16 1.7 0.18 466 0.91

Lip, oral cavity 161 21 1.3 0.15 67 18 0.53 0.06 472 0.92

Kidney 152 22 1.4 0.14 56 21 0.46 0.05 492 0.96

Penis 66 23 1.1 0.10 19 27 0.31 0.03 182 0.36

Melanoma 59 24 0.49 0.05 34 24 0.27 0.03 199 0.39

Vagina 57 25 0.92 0.09 24 26 0.37 0.04 151 0.29

Nasopharynx 55 26 0.49 0.06 32 25 0.28 0.03 169 0.33

Gallbladder 55 27 0.44 0.05 41 23 0.32 0.04 80 0.16

Salivary glands 54 28 0.45 0.04 11 30 0.08 0.01 168 0.33

Kaposi sarcoma 33 29 0.29 0.03 12 29 0.10 0.01 97 0.19

Hypopharynx 28 30 0.26 0.04 12 28 0.11 0.01 52 0.10

Vulva 10 31 0.13 0.01 5 32 0.06 0.00 27 0.05

Testis 9 32 0.14 0.01 4 33 0.06 0.01 30 0.06

All cancers 20 171 - - 17.2 11 744 - - 9.3 51 313 -

All cancers excl. NMSC 19 887 - - 17.0 11 653 - - 9.3 50 298 -

Data source and methods

Incidence Incidence Mortality Males Females

Country-specific data source: No data Prostate 86.1 31.1 Prostate 86.1

Method: Estimated from national mortality estimates by Breast 53.4 23.0 Breast 53.4

modelling, using mortality:incidence ratios derived from survival

Cervix uteri 15.6 9.9 Colorectum 16.2 13.2
estimation
Colorectum 14.7 7.6 Cervix uteri 15.6

Mortality Lung

Liver
12.8

6.8
10.9

5.9
Lung

Liver
15.1

7.7
10.8

6.0

Country-specific data source: National (WHO) Stomach 6.2 4.7 Stomach 7.2 5.3

Method: National rates projected to 2022

Leukaemia 5.5 4.7 Leukaemia 6.6 4.5

Prevalence
Pancreas 5.0 4.4 Pancreas 5.8 4.3

Brain CNS 3.4 2.7 Larynx 4.3 1.2

Computed using sex-; site- and age-specific incidence to 1-;3- Corpus uteri 3.4 1.0 Brain CNS 3.9 3.0

and 5-year prevalence ratios from Nordic countries for the period
Larynx 2.7 1.7 Corpus uteri 3.4

(2011-2020), and scaled using Human Development Index (HDI)

Ovary 2.7 1.7 NHL 2.8 2.3
ratios.

NHL 2.6 1.4 Bladder 2.8 1.3

Thyroid 2.3 0.3 Ovary 2.7

120 100 80 60 40 20 0 20 40 60 80 100 120 120 100 80 60 40 20 0 20 40 60 80 100 120

ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**

Page 2

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today